Reduced
3.35% -> 2.75%
Greenlight Capital sold 148,005 shares; portfolio weight moved from 3.35% to 2.75%.
Estimated quarter price range
Price estimate unavailable.
-148,005 Shares
-4.84%
Back to 13F signals
Unclassified
TEVA PHARMACEUTICAL INDS LTD
Current managers
3
Company market cap
Unavailable
No reliable live market-cap source is available for this company.
Estimated quarter price range
Latest four quarters with available market data.
0
Q1 2026Price estimate unavailable.
Q4 2025Price estimate unavailable.
Q3 2025Price estimate unavailable.
Q2 2025Price estimate unavailable.
Price estimate unavailable.
Latest 13F signals for this stock
Counts show how tracked institutions changed this company in their latest available filings.
3
New position
0
Increased
1
Reduced
2
Exited
0
Who holds it and what changed this quarter
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
SEC05/15/2026
Increased
0.09% -> 0.15%
Bridgewater Associates added 374,313 shares; portfolio weight moved from 0.09% to 0.15%.
Estimated quarter price range
Price estimate unavailable.
+374,313 Shares
+49.64%
Reduced
0.02% -> 0.02%
ARK Invest sold 36,852 shares; portfolio weight moved from 0.02% to 0.02%.
Estimated quarter price range
Price estimate unavailable.
-36,852 Shares
-35.05%
SEC source transparency
Signals are derived from SEC EDGAR 13F information tables. Search aliases, tickers, themes, and company mappings help discovery but do not replace the original filing.
Data source
SEC EDGAR
Source filings
16
Latest reporting quarter
2026Q1
Four-quarter trend
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Historical and source details
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
Quarterly holdings details
| Quarter | Current managers | Combined holding value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 2 | $65,358,150 | 3,899,651 | ARK Invest New position - 120,874 Shares Greenlight Capital New position - 3,778,777 Shares |
| Q3 2025 | 3 | $96,198,055 | 4,762,280 | Bridgewater Associates New position - 864,782 Shares ARK Invest Reduced - 118,721 Shares Greenlight Capital Unchanged - 3,778,777 Shares |
| Q4 2025 | 3 | $122,279,470 | 3,917,958 | Bridgewater Associates Reduced - 754,093 Shares ARK Invest Reduced - 105,131 Shares Greenlight Capital Reduced - 3,058,734 Shares |
| Q1 2026 | 3 | $123,715,310 | 4,107,414 | Bridgewater Associates Increased - 1,128,406 Shares ARK Invest Reduced - 68,279 Shares Greenlight Capital Reduced - 2,910,729 Shares |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Holding market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Greenlight Capital | TEVA PHARMACEUTICAL INDS LTD | 881624209 | SPONSORED ADS | $87,671,158 | 2,910,729 | 2.75% | SEC XML |
| Bridgewater Associates | TEVA PHARMACEUTICAL INDS LTD | 881624209 | SPONSORED ADS | $33,987,589 | 1,128,406 | 0.15% | SEC XML |
| ARK Invest | Teva Pharmaceutical Industries | 881624209 | ADR | $2,056,563 | 68,279 | 0.02% | SEC XML |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.